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Key messages 
 
 The use of EG for wound healing has been on the rise of late, however, data to date 
on the outcome and treatment group has been heterogeneous  
 This systematic review synthesises the current evidence on EG for wound healing to 
establish the efficacy of this technique in the clinical setting, by measuring the 
proportion of wounds healed and the mean wound healing time.  
 EG offers a healing rate of over 70 percent with mean healing time of five weeks and 
allows painless autologous skin grafting to be performed without donor site morbidity.  
 
 
 
 
 
4 
 
Abstract 
 
Autologous skin grafting is an important method for wound coverage; however, it is an 
invasive procedure and can cause donor site morbidity. Epidermal grafting (EG) enables 
epidermal transfer to wound with minimal donor site morbidity. However, data to date has 
been heterogeneous. This study aims to synthesise the current evidence on EG for wound 
healing to establish the efficacy of this surgical technique. A comprehensive search in the 
MEDLINE, EMBASE and CENTRAL database was conducted. The endpoints assessed were; 
proportion of wounds healed and mean wound healing time. This systematic review was 
conducted and reported according to the Meta-Analysis of Observational Studies in 
Epidemiology (MOOSE) guidelines. We identified 1568 articles, of which 7 articles were 
included in this review; a total of 209 wounds in 190 patients. The mean wound duration was 
17.06 weeks (95% c.i. 8.57 to 25.55). Of these, 71.5%(95% c.i. 56.7 to 84.2) of the wounds 
achieved complete healing. Mean time for complete wound healing was 5.53 weeks (95% c.i. 
3.18 to 7.88). The mean donor site healing time was 7.48 days (95% c.i. 4.83 to 10.13), with 
no reported donor site morbidity. The current data are small and lacks level 1 evidence.  
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Introduction 
 
Wound care presents a significant financial and resource burden to the healthcare system, 
reported to account for over 5 percent of National Health Service (NHS) expenditure. Between 
£2⋅3–£3⋅1 billion is spent in caring for patients with chronic wounds in the United Kingdom 
alone (1). Chronic wounds account for a burdening problem with over 100,000 new ulcers 
anticipated every year, with an ageing population and rising prevalence of obesity and 
diabetes (2).  
In most cases management is conservative, by wound care and dressings. Intervention by 
autologous skin grafting is an important modality for wound coverage (3). Skin grafting can 
be classified based on the thickness of the harvested skin, namely, full thickness skin graft 
(FTSG), split thickness skin graft (SSG) and epidermal graft (EG) (4, 5). 
FTSG consists of the epidermis and the entire dermis of the skin. FTSG is normally reserved 
for smaller wounds as the donor site must be closed primarily. Thus, only selected areas with 
sufficient skin laxity is suitable for skin harvest, commonly the retroauricular area, 
cervicopectoral area, and groin (3). Larger areas can be managed by SSG which involves 
shaving the epidermis and part of the dermis of the skin. This is best performed by an electric 
air dermatome and the donor site regenerates by secondary intention from the residual 
reticular dermis (3). SSG is the commonest form of autologous skin grafting performed and 
can be meshed to cover a wide surface area. A major consideration for SSG is that the donor 
site may itself develop as a second, often painful wound, which may take more time to heal 
than the graft site itself and holds the risk of infection and scarring (6). Both the FTSG and SSG 
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often require hospital admission, even as a day case, anaesthesia, and a period of immobility 
for some patients.  
EG, on the other hand, is an emerging and promising option. EG involves harvesting only the 
epidermal layer of the skin from the donor site by applying continuous negative pressure on 
the normal skin to raise blisters (Figure 1). The roof of the blister, which is the epidermis, is 
then excised and transferred onto the wound. As the dermis in the donor site remains 
untouched, the skin regenerates itself without scar. This procedure is also often painless as 
the pain fibres in the dermis are unstimulated, allowing autologous skin grafting in the 
outpatient setting without administration of anaesthesia and with minimal donor site 
morbidity(7). 
The use of EG for wound healing has been on the rise of late, with several recent publications 
in the last couple of years. However, data to date have been heterogeneous on the outcome 
and on when and in which patient group this surgical technique should be employed. This 
systematic review synthesises the current evidence on EG for wound healing to establish the 
efficacy of this technique in the clinical setting, by measuring the proportion of wounds 
healed and the mean wound healing time. It is timely that the evidence is assessed to guide 
clinical decision making and to further facilitate future research. 
 
Materials and methods 
 
The protocol for this systematic review was registered with the PROSPERO international 
prospective registration of systematic reviews (registration number: CRD42016033051), and 
a detailed protocol was peer reviewed and published(8). There is no deviation from the 
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published protocol. This systematic review was conducted and reported according to the 
Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines (9).  
Search strategies  
We searched the MEDLINE (OvidSP), EMBASE (OvidSP), and Cochrane Central Register of 
Controlled Trials (CENTRAL) database from 1946 until December 2016 to identify studies of 
relevance to this review. The search strategy included a combination of text words and 
Medical Subject Headings (MeSH) terms relating to the use of EG for treating wounds. No 
language or publication restrictions were applied. The reference list of all articles included 
were cross-checked for further articles of relevance. A sample search strategy for MEDLINE 
(OvidSP) is shown and similar strategy was adapted for other databases.  
1. [epidermal graft*] OR [blister graft*] OR [suction blister*] OR [suction graft*] 
2. Epidermis/su, tr [Surgery, Transplantation] 
3. [1] or [2]  
Inclusion criteria 
The inclusion criteria used were: (i) studies involving adult patients above 18 years old; (ii) EG 
for wound healing; (iii) English language; (iv) available information containing at least the 
following: number of subjects, method of EG harvest, and healing time.  
Exclusion criteria 
The exclusion criteria were: case reports or case series of ten or lesser patients; studies 
describing the use of EG in skin pigmentation disorder such as vitiligo; studies combining EG 
with other treatments such as stem cells or dermal substitutes; and studies describing only 
the harvest technique without treatment outcome. 
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Outcome measures 
The primary efficacy outcomes measured were the proportion of wounds healed and the 
mean wound healing time (time for complete healing). Secondary outcome measures were 
the mean donor site healing time, need for anaesthesia, economic evaluation based on the 
cost associated with resources used, health-related quality of life, and proportion of patients 
with adverse event. Subgroup analysis was performed for the proportion of wounds with 
complete healing based on the wound aetiology.  
Study selection 
The retrieved articles’ titles and abstracts were scanned for potential eligibility, using the 
predetermined selection criteria, after excluding duplicate records. Full-text review was 
undertaken for studies that met the inclusion criteria. Abstracts and conference proceeding 
without full text were not included because of the difficulty in evaluating incomplete 
information. Ongoing trials without complete data were not included. 
Data extraction 
Data from all full-text articles accepted for final analysis were independently retrieved by two 
authors (M.K. and O.J.S.) using a standardised data extraction form. Discrepancies were 
resolved by discussion. The following data were extracted: study characteristics (first author, 
year of publication, country, study design), patient demography (number of studied subjects, 
sex, mean age, comorbidity, number of wounds treated), wound characteristics (wound 
aetiology, mean wound duration, mean wound size, pre-grafting wound quality), 
characteristics of EG harvest technique, use of anaesthesia, outcomes (wound healing time, 
number and type of wounds with 100 percent healing, number of wounds with 50-99 percent 
healing, number and type of wounds failed to heal, donor site healing time), and 
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complications or adverse events. Data were extracted from the studies as presented or were 
calculated (e.g.: mean age and mean wound size).  
Assessment of risk of bias of included studies 
A formal risk of bias assessment was not performed as the included studies were mostly small 
case series.  
Data analysis and synthesis 
The main outcome measures of the included studies were the pooled estimate of the 
proportions of wounds healed, the mean wound healing time, and the mean donor site 
healing time with the corresponding 95 percent confidence intervals (c.i.). Meta-analysis of 
proportion was performed for the proportion of wounds healed. Meta-analysis of summary 
was performed for the mean wound and donor site healing time, mean wound size, mean 
wound duration and mean age of the patients. The clinical and methodological heterogeneity 
were assessed. Random effects model was used for the pooled estimates as the included 
studies demonstrated high clinical and statistical heterogeneity (10). The outcomes were 
analysed using StatsDirect Statistical software (StatsDirect statistical software, version 2.8.0; 
StatsDirect, Altrincham, UK).  
 
Results 
 
Literature search results 
We found 1102 articles in the MEDLINE database search, 961 articles in the EMBASE database 
search, and 271 articles in the CENTRAL database search. References from these three 
searches were combined and after removing the duplicates, 1568 articles were available for 
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title and abstract reviewing. Of these, 1395 articles did not meet the inclusion criteria and 
were excluded. Following full text review of the remaining 173 articles, 166 articles were 
excluded as the inclusion criteria was not met. A total of 7 articles were included and formed 
the basis of this systematic review(7, 11-16) (Figure 2). Cross-checking of the reference list 
revealed that no article was missed by the initial search. Details of the included studies are 
summarised in Table 1.  
Wound healing outcome 
A total of 209 wounds in 190 patients were treated with EG, with the average wound size of 
20.18 cm2 (95 percent c.i. 8.19 to 32.17). The mean age of the patients was 62.62 years (95 
percent c.i. 55.56 to 69.69). The mean wound duration of the 128 reported wounds was 17.06 
weeks (95 percent c.i. 8.57 to 25.55). 
The number of wounds that achieved complete wound healing was reported in six studies 
involving 137 wounds. The proportion of wounds that achieved complete healing was 71.5 
percent (95 percent c.i. 56.7 to 84.2) (Figure 3), with the mean time for complete wound 
healing of 5.53 weeks (95 percent c.i. 3.18 to 7.88) (Figure 4). The proportion of complete 
healing for the CelluTome Epidermal Harvesting System alone, which was used in 4 of the 
studies, was 73.5 percent (95 percent c.i. 54.0 to 89.1), with the mean healing time of 5.91 
weeks (95 percent c.i. 3.81 to 8.05). 
EG was used to treat wounds of various aetiologies, duration and size. The following wide 
range of wounds were treated: venous ulcer (n=34), arterial ulcer (n=4), mixed arteriovenous 
ulcer (n=3), diabetic ulcer (n=7), rheumatoid ulcer (n=9), vasculitis (n=9), trauma (n=18), burns 
(n=1), SSG donor site (n=3), pyoderma granulosum (n=1), and lymphoedema (n=1) (Table 2). 
Most of the treated wounds were chronic wounds (more than or equal to three months in 
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duration), except for 13 wounds that were acute wounds (less than three months in duration). 
All treated diabetic foot ulcer, SSG donor site, and burns wounds achieved complete healing 
(Table 2). Wounds of other aetiologies demonstrated a lower success rate (Table 2).  
Partial healing of between 50-99.9 percent healing was achieved by 14.0 percent (95 percent 
c.i. 2.7 to 31.9) of the wounds within the follow up duration while failure or no healing (0-49.9 
percent healing) was reported in 13.5 percent (95 percent c.i. 8.3 to 19.8) of the wounds. The 
failures were mainly attributed to wound infection. There was lack of reporting on the time 
for partial healing and there was no consistency in the follow up duration in the included 
studies.  
Donor site healing 
Three different EG harvesting systems were used: Dermovac (Oy Instrumentarium, Helsinki, 
Finland), the syringe system, and the CelluTome Epidermal Harvesting System (Acelity, San 
Antonio, Texas). Although these systems harvest different sizes of grafts, they share the 
similar harvest principle that applies continuous negative pressure on normal skin to raise 
blisters. The donor site healing time was reported in three studies involving 59 patients, 
whereby one study used the Dermovac system while two studies used the CelluTome 
Epidermal Harvesting System.  
The pooled mean donor site healing time was 7.48 days (95 percent c.i. 4.83 to 10.13). The 
donor site healing time of the CelluTome Epidermal Harvesting System alone, which is the 
latest EG harvesting system, is 6.21 days (95 percent c.i. 4.73 to 7.68). The Dermovac system, 
which raises blisters measuring 5-15 mm, has a donor site healing time of 10 days (13).  
Hentzer et al. reported slight diffuse pigmentation at the donor site while Costanzo et al. 
reported occasional hypopigmentation by the Dermovac system, but all donor sites healed 
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without scar (11, 13). The donor site healing time and quality of the donor site healing by the 
syringe system was not reported by any of the included studies.  
Use of anaesthesia 
Only one study reported on the use of local anaesthesia during graft harvest which used the 
syringe system. In this retrospective study, Hanafusa et al. compared pain during harvest 
using syringes of different sizes (5ml, 10ml and 20ml) with and without the use of anaesthesia 
(12). Pain at graft harvest was eliminated among patients that received local anaesthesia 
(n=27), while 50 percent of patients (n=34) without local anaesthesia felt pain. However, the 
pain severity at harvest was not reported using a validated pain measurement scale. By 
contrast, the CelluTome Epidermal Harvesting System and the Dermovac system, which 
harvests multiple small blisters, were reported to be painless even without the administration 
of local anaesthesia although this was also not reported using a pain measurement scale.  
Cost, quality of life and adverse events 
None of the included articles measured the health-related quality of life or patient 
satisfaction. The economic evaluation of the various harvesting systems was also not 
reported. No adverse events were reported in any study. 
 
Discussion 
 
The aim of this systematic review was to evaluate the efficacy of epidermal grafting for wound 
healing. We found 7 articles, no randomised controlled trials exist now. The current evidence 
on the efficacy of epidermal grafting involves small case-series with huge heterogeneity in the 
study population.  
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We found that complete healing was achieved by 71.5 percent (95 percent c.i. 56.7 to 84.2) 
of the wounds with the mean time for complete healing of 5.53 weeks (95 percent c.i. 3.18 to 
7.88). Although none of the studies compared the healing outcome with conservative 
management or SSG, previous data suggests that the healing outcome is comparable with 
SSG which has a healing rate of 73 percent (17).  The average time for complete donor site 
healing was 7.48 days (95 percent c.i. 4.83 to 10.13), with no reported donor site morbidity. 
EG was performed on wounds of various aetiologies, duration and size. The diabetic foot 
ulcer, burn wound, and SSG donor site wounds achieved complete healing while wounds due 
to lymphoedema and pyoderma granulosum failed to heal. Despite demonstrating the wide 
applicability of this technique, there was a lack in the consistency in between studies to make 
a strong recommendation on the type of wound that would best benefit from this treatment.  
In this review, we managed to highlight the overall success rate of EG for wound healing and 
the mean wound and donor site healing time which was previously unclear. Although the 
success rate of EG in direct comparison to SSG is yet to be not known, the lack of donor site 
morbidity and the ability to perform this procedure in the outpatient setting without the use 
of local anaesthesia are the major advantages that this technique offers over conventional 
techniques. The mechanism of healing between EG and SSG is expected to be different, 
whereby EG is expected to behave more like a bioactive dressing which stimulates the wound 
bed to regenerate (reviewed in ref. (5)). The difference in the success rate between the 
various wound aetiologies suggest that the EG is sensitive to the microenvironment of the 
wound. This also suggests that post grafting wound care should be specific to the wound 
aetiology.  
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The various EG harvesting systems used in the included studies varied in the amount of 
negative pressure generated and the size of graft harvested despite relying on the similar 
principle. The EG harvesting system that was most widely used in the included studies was 
the CelluTome Epidermal Harvesting System, which was used by four of the studies. This 
system has the shortest graft harvest time, fastest donor site healing, no reported donor site 
morbidity, and can be performed in outpatient setting without anaesthesia. Being an 
automated system, the procedure is easily reproducible with consistent graft quality. The 
shorter harvest time is contributed by the high negative pressure which is applied 
concurrently with the thermal energy of 40oC and its design which harvests an array of 128 
micro-blisters, each of 2mm diameter and spaced 2mm apart, within an area measuring 5cm 
x 5cm (18). The earlier systems used to harvest EG, which is the Dermovac and the syringe 
system faced several challenges which limits its clinical applicability. The Dermovac, which 
has an adapter plate that allows user to determine the number and size of blisters to be 
harvested, has a long harvest time and requires a large equipment(19). The reliability of the 
syringe system, on the other hand, had been described to depend on numerous patient and 
environmental factors, requires skill, time consuming, causes pain and tedious to use with 
often inconsistent blister shape and size formation (18). 
The evidence in this study is limited by the lack of high-quality, level-1 evidence. The existing 
studies were mostly small, retrospective case-series and single-centre cohort studies that are 
often at risk of bias. There were no comparative data to evaluate that healing outcome of EG 
against the current standard of care such as advanced dressings or SSG. Formal bias 
assessment was not performed due to the study design of the included studies. In terms of 
the search strategy, as there is no Medical Subject Heading (MeSH) term available for EG, 
potentially valuable and informative studies published with other keywords may therefore 
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been missed. Further, several different harvesting systems were used in the included studies. 
Proportion of healing based on the size and depth of wound as well as device utilized were 
not performed due to incomplete reporting in most of the studies. Similarly, subgroup 
analysis for healing based on the wound aetiology was not performed due to the broad 
heterogeneity in the study population. The EG harvested by the different harvest systems 
were assumed to produce similar graft quality for the purpose of this review as the grafts 
were all harvested by blister formation. 
In conclusion, EG offers a healing rate of over 70 percent and allows painless autologous skin 
grafting to be performed without donor site morbidity. The rapid donor site healing could 
have a major impact in the patient’s quality of life. Our conclusions are limited by the small 
size and heterogeneity of the studies and the different techniques of EG. Methodologically 
sound randomised controlled trials to compare EG against SSG or conservative treatment are 
necessary.  
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Table 1  
Overview of the included studies 
Citation Hentzer B et al, 
1975(13) 
Costanzo U et 
al, 2006(11) 
Hanafusa T et 
al, 2008(12) 
Bhatia A, 
2016(16) 
Cai SS et al, 
2016(15) 
Hachach-Haram N 
et al, 2016(7) 
Prakash TV et al, 
2016(14) 
Year 1975 2006 2008 2016 2016 2016 2016 
Country Denmark Switzerland Japan India USA UK India 
Study type Case series Case series Case series Case series Case series Case series Case series 
Number of patients 12 18 61 34 12 35 18 
Male N/R 5 N/R 17 6 16 9 
Mean age (year) N/R 76.5 I/R 67.1 ± 13.8 57.1 ± 19.1 66.1 ± 21.1 54.1 ± 10.8 
Number of wounds 12 29 69 34 12 35 18 
Mean wound     
  duration (week) 
N/R 21±178.7 I/R 13.7 ± 15.0 14.6 ± 18.3 19⋅4±24⋅0 147.2 ± 194 
Average wound size  
  (cm2) 
N/R 6.70 ± 5 27.80 ± 7.10 N/R 49.1 ± 77.6 20.5 ± 22.4 N/R 
Epidermal graft        
  harvesting  
  technique 
          
Device Suction device 
Dermovac® 
Suction cups 
with oil rotary 
vacuum pump 
Syringe  CelluTome CelluTome CelluTome CelluTome 
Negative pressure 
(mmHg) 
250-300 mmHg 200-300 N/R 400-500 400-500 400-500 400-500 
Duration 1-2 Hours 2 to 3 hours 16-128 minutes 30-45 
minutes 
30-45 
minutes 
30-50 minutes 20-45 minutes 
Use of anaesthesia No No LA in 27 
patients 
No No No No 
Donor site dressing N/R Antiseptic 
cream and 
gauze 
N/R N/R Tegaderm Tegaderm Gauze or 
Tegaderm 
Wound site dressing Gauze + wet 
dressing with 
2% boric acid. 
Non-adherent 
dressing (Sofra-
Tulle), gauze, 
compression 
bandage 
N/R N/R Negative 
pressure 
wound 
therapy 
Adaptic Touch + 
secondary 
dressing (iNadine 
or Aquacel) 
Gauze 
20 
 
Wounds with  
  complete healing 
10 16 18 28 4 22 16 
Duration for  
  complete healing 
(week)  
2 ± 1.98 3.6 ± 1.98 8.3 ± 0.9 7 ± 6.6 10.6 ± 5.28 5⋅91±3⋅48 3.7± 1.8 
 
Wounds with 50-   
  99% healing 
1 10 N/R 0 5 6 0 
Number of failure 1 3 N/R 4 0 (3 patients 
lost to follow 
up) 
7 1 
Donor site healing 10 days N/R N/R N/R 1 week 5⋅49±1⋅48 days N/R 
Legend:  N/R=Not reported I/R=Incomplete reporting 
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Table 2 
Healing by wound aetiology 
 
Wound aetiology Number 
treated 
Completely 
healed wounds 
Percentage healed 
(%) 
Diabetic foot ulcer 7 7 100.00% 
SSG donor site 3 3 100.00% 
Burn 1 1 100.00% 
Venous 34 33 97.06% 
Arterial 4 3 75.00% 
Mixed 3 2 66.67% 
Rheumatic disease 9 6 66.67% 
Trauma 18 12 66.67% 
Vasculitis 9 5 55.56% 
Pyoderma granulosum 1 0 0.00% 
Lymphatic 1 0 0.00% 
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Figure 1 
Illustration of the skin layers involved in autologous skin graft harvest. 
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Figure 2 
Flow diagram of literature search 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records after duplicates removed  
(n = 1568) 
Records excluded  
(n = 1395) 
Full-text articles assessed 
for eligibility  
(n = 173) 
Full-text articles excluded, with 
reasons  
(n = 166) 
animal model = 1 
blister fluid analysis = 2 
case report ≤ 10 cases = 9 
chemical separation of epidermis/non-
suction harvest = 1 
conference proceeding = 2 
donor site healing = 16 
histology = 3 
non-english = 4 
vitiligo = 98 
other skin diseases = 7 
technical description = 23 
tissue engineering = 1 
 
Studies included in 
qualitative synthesis  
(n = 7) 
Records screened  
(n = 1568) 
Records identified through 
database searching  
(n = 2334) 
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Figure 3 
Meta-analysis of proportion of wounds with complete healing (random-effects plot). 
Proportions are shown with 95 per cent confidence intervals. 
 
  
Proportion meta-analysis plot [random effects]
0.0 0.2 0.4 0.6 0.8 1.0
combined 0.71 (0.57, 0.84)
Prakash TV et al, 2016 0.94 (0.73, 1.00)
Nadine HH et al, 2016 0.63 (0.45, 0.79)
Cai SS et al, 2016 0.44 (0.14, 0.79)
Bhatia A, 2016 0.82 (0.65, 0.93)
Costanzo et al, 2006 0.55 (0.36, 0.74)
Hentzer B et al, 1975 0.83 (0.52, 0.98)
proportion (95% confidence interval)
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Figure 4 
Meta-analysis of summary of time for complete wound healing (random effect plot). 
Proportions are shown with 95 per cent confidence intervals. 
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